Circulating CD9+-EVs from COVID-19 patients were initially isolated by a two-step purification procedure involving 120,000 xg ultracentrifugation of plasma samples that generate p120 fractions followed by CD9+-EVs magnetic immunocapture. The gene discussed is CD9; the disease is COVID-19.